Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The (MAD) portion of SDC-1801 is nearing completion, not the whole trial.
According to here: last patient enrollment 7 May 24, last data collection 4 June 24
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12623000416695
But Basil if you've made 200% on a share it's actually disciplined investing to take profits. I haven't as I'm underwater on my earlier purchases here but I can see why others have.
"The multiple ascending dose (MAD) portion of SDC-1801 is nearing completion. Sareum aims to conclude this part of the trial by the end of Q2 2024. Subject to data review, additional funding and/or potential licencing opportunities, we endeavour to be in a position to commence a Phase 2a study in psoriasis patients before the end of 2024."
Top-line data is expected to be available in Q2 2024 was the wording on the Half-year report of 28 March 2024. We are already a month into Q2 2024, so it is due soon.
Who says the rns is due is days of maybe weeks ?
I'm expecting to see it drift a bit lower and consolidate after a fantastic 200%+ rise from the 8p area
Thats quite a run given the market we are in
Think most would be happy to hold in the 20p range over the coming weeks
Still 100%+ up from the lows and the 10p placing
There's a lot of chat about base prices, where the SP is going and support etc.
Very difficult to pin anything like that down due to the subscription shares being issued on Friday, there's still some RF selling to come. That is the one thing holding back the SP at the moment, when they clear their final tranche, we should see some stabilisation to more realistic levels, possibly likely to coincide with news.
For now GLA and see you in a few months for the Phase 1 RNS
I would prefer to see a higher base SP prior to the news release. It's still very low atm.
You may be right but I dont think there are many seller bellow 30p and I don't think it gapped up, it gapped down so I think the gaps are filled.
With topline data for the P1 trial of SDC-1801 due out very soon it is certainly risky to be day trading SAR between now and that RNS, especially as we know that to date SDC-1801 has been highly effective. e.g. it has already demonstrated a profile superior to the anti-inflammatory steroid dexamethasone and similar to the JAK1/JAK2 inhibitor baricitinib. When that data was RNS'd on July 1st 2021 the share price climbed over the next few weeks to over 450p. If we get a similar positive RNS from Oz in the coming days / weeks we should see a significant climb in the Sareum share price.
Lets check in tomorrow and see. When a stock gaps up and spikes like this then reverses same day. Its often refered to as a blow off top
Closing the daily at the lows indicates more downside tomorrow
I don't make the rules
Imo, the re-trace is done, and this is the new trading range.
IG - who do you work for.. oh hang on… that’s a very large portfolio and lots of your GCM predictions haven’t come to pass.
Fine that you express your opinion but forgive us if we just follow the news and the science. Thanks though
Not desperate, just saying it how it is
I said the same on GDR when it spiked to 10p... Cooled off back to 5p now
In this market a 250% rise from the lows requires some back testing and consolidation before continuing higher
20p is an obvious place for ap ullback imho
How about needs to get back to 100p level to consolidate as been way way oversold
I agree, it will hopefully slowly climb over the next few days and gain momentum. It's only this low due to profit takers from this morning.
Plenty of support @30p the last time I looked.
You seem desperate genius ....this will not go to 20p but good luck....
Got a bit overbought and ahead of itself
Looking for 20p area to provide support after a nice run from 9/10p area
Again. If this was true, that would be an incredibly long game someone was playing. the consolidation was Dec 21. Nearly 2nd a half years ago. There is a tendency, especially in the social media, and internet age to not trust the narrative, citing they are all out to get us. When in reality, we probably had ideas above our station and the board (and shareholders)have been brought down a peg or two. I'm not saying there is no corruption as there always is but in Sareums case, we've been shown to be lacking in some areas and exposed as the AIM minnow we actually are. Big learning opportunity for me and all to play for as far as I'm concerned.
Nicely, if someone told you a snowman was white you’d still have a contradictory view.
May have a lil rise
Smart - we had the RNS yesterday. We wont get anything else.
''the consolidation was a deliberate play to make dilution and a possible take-over easier... and that they already had Riverfort in mind as the executioner''.
No prizes for guessing who the architect would have been in all of the above (IMHO) and we actually pay them a fee for the privilege! 😡🤬😡
The sooner they are gone the better!!!